|
US8299248B2
(en)
|
2006-08-02 |
2012-10-30 |
Cytokinetics, Incorporated |
Certain 1H-imidazo[4,5-b]pyrazin-2(3H)-ones and 1H-imidazo[4,5-b]pyrazin-2-ols and methods for their use
|
|
MX2012007367A
(es)
|
2009-12-30 |
2013-04-03 |
Arqule Inc |
Compuestos substituidos de imidazopiridinilo-aminopiridina.
|
|
KR101477156B1
(ko)
*
|
2010-08-25 |
2014-12-29 |
(주)네오팜 |
신규한 헤테로고리 화합물 및 이를 이용한 염증성 질환 치료용 조성물
|
|
EP3170813B1
(en)
|
2010-10-06 |
2018-12-12 |
GlaxoSmithKline LLC |
Benzimidazole derivatives as pi3 kinase inhibitors
|
|
CN103582632B
(zh)
|
2011-03-31 |
2015-08-19 |
拜耳知识产权有限责任公司 |
取代的苯并咪唑
|
|
WO2012177852A1
(en)
|
2011-06-24 |
2012-12-27 |
Arqule, Inc |
Substituted imidazopyridinyl compounds
|
|
KR101974673B1
(ko)
|
2011-06-24 |
2019-05-02 |
아르퀼 인코포레이티드 |
치환된 이미다조피리디닐-아미노피리딘 화합물
|
|
EP2865672A4
(en)
*
|
2012-06-22 |
2015-12-16 |
Sumitomo Chemical Co |
CONDENSED HETEROCYCLIC COMPOUND
|
|
CN102924460B
(zh)
*
|
2012-11-05 |
2015-12-16 |
南京师范大学 |
一种4H-吡咯并[1,2-a]苯并咪唑衍生物及其合成方法和应用
|
|
US9073878B2
(en)
|
2012-11-21 |
2015-07-07 |
Zenith Epigenetics Corp. |
Cyclic amines as bromodomain inhibitors
|
|
WO2014080291A2
(en)
|
2012-11-21 |
2014-05-30 |
Rvx Therapeutics Inc. |
Biaryl derivatives as bromodomain inhibitors
|
|
WO2014096965A2
(en)
|
2012-12-21 |
2014-06-26 |
Rvx Therapeutics Inc. |
Novel heterocyclic compounds as bromodomain inhibitors
|
|
CN103130811B
(zh)
*
|
2013-03-11 |
2015-02-25 |
河南师范大学 |
一种5,6-二氢吡唑并[1,5-c]喹唑啉类化合物的合成方法
|
|
WO2014151367A1
(en)
|
2013-03-15 |
2014-09-25 |
Janssen Pharmaceutica Nv |
1,2,5-substituted benzimidazoles as flap modulators
|
|
US9695149B2
(en)
|
2013-03-15 |
2017-07-04 |
Janssen Pharmaceutica Nv |
1,2,6-substituted benzimidazoles as flap modulators
|
|
US9512120B2
(en)
|
2013-03-15 |
2016-12-06 |
Syngenta Participations Ag |
Microbicidally active imidazopyridine derivatives
|
|
SG11201510409QA
(en)
|
2013-06-21 |
2016-01-28 |
Zenith Epigenetics Corp |
Novel bicyclic bromodomain inhibitors
|
|
WO2015004533A2
(en)
|
2013-06-21 |
2015-01-15 |
Zenith Epigenetics Corp. |
Novel substituted bicyclic compounds as bromodomain inhibitors
|
|
WO2015015318A2
(en)
|
2013-07-31 |
2015-02-05 |
Zenith Epigenetics Corp. |
Novel quinazolinones as bromodomain inhibitors
|
|
KR102254957B1
(ko)
|
2013-11-22 |
2021-05-25 |
씨엘 바이오사이언시즈 엘엘씨 |
골다공증 치료 및 예방을 위한 가스트린 길항제(eg yf476, 네타제피드)
|
|
CN103965136B
(zh)
*
|
2014-05-07 |
2016-09-07 |
苏州波菲特新材料科技有限公司 |
一种制备n-甲基噻唑啉-2-酮类化合物的方法
|
|
EP3227280B1
(en)
|
2014-12-01 |
2019-04-24 |
Zenith Epigenetics Ltd. |
Substituted pyridines as bromodomain inhibitors
|
|
US10710992B2
(en)
|
2014-12-01 |
2020-07-14 |
Zenith Epigenetics Ltd. |
Substituted pyridinones as bromodomain inhibitors
|
|
JP2017537946A
(ja)
|
2014-12-11 |
2017-12-21 |
ゼニス・エピジェネティクス・リミテッドZenith Epigenetics Ltd. |
ブロモドメイン阻害剤としての置換複素環
|
|
HK1245247A1
(zh)
|
2014-12-17 |
2018-08-24 |
恒翼生物医药科技(上海)有限公司 |
溴结构域的抑制剂
|
|
RU2750151C2
(ru)
|
2015-11-20 |
2021-06-22 |
Форма Терапьютикс, Инк. |
Гипоксантины в качестве ингибиторов убиквитин-специфической протеазы 1
|
|
CN106519250A
(zh)
*
|
2016-09-29 |
2017-03-22 |
辽宁石油化工大学 |
含氮小分子有机配体调节荧光发射性质的一维链状铜配位聚合物的制备方法
|
|
GB201617630D0
(en)
|
2016-10-18 |
2016-11-30 |
Cellcentric Ltd |
Pharmaceutical compounds
|
|
EP3562306B1
(en)
|
2016-12-29 |
2025-02-26 |
Ji Xing Pharmaceuticals Hong Kong Limited |
Metalloenzyme inhibitor compounds
|
|
EP3562487B1
(en)
|
2016-12-29 |
2023-11-29 |
Ji Xing Pharmaceuticals Hong Kong Limited |
Metalloenzyme inhibitor compounds
|
|
MX388196B
(es)
|
2017-04-26 |
2025-03-19 |
Basilea Pharm Int Ag |
Procesos para la preparacion de furazanobencimidazoles y formas cristalinas de estos.
|
|
CA3069720A1
(en)
|
2017-07-11 |
2019-01-17 |
Vertex Pharmaceuticals Incorporated |
Carboxamides as modulators of sodium channels
|
|
TWI846350B
(zh)
|
2017-09-15 |
2024-06-21 |
美商佛瑪治療公司 |
作為CBP/p300抑制劑之四氫-咪唑並喹啉化合物
|
|
GB201800688D0
(en)
|
2018-01-16 |
2018-02-28 |
Redag Crop Prot Ltd |
Agricultural chemicals
|
|
GB201806320D0
(en)
|
2018-04-18 |
2018-05-30 |
Cellcentric Ltd |
Process
|
|
MX2023013508A
(es)
|
2018-06-29 |
2023-12-13 |
Forma Therapeutics Inc |
Inhibicion de la proteina de union a creb (cbp).
|
|
HUE066335T2
(hu)
|
2018-10-05 |
2024-07-28 |
Annapurna Bio Inc |
Vegyületek és készítmények APJ receptor aktivitáshoz kapcsolódó állapotok kezelésére
|
|
US12358893B2
(en)
|
2019-01-08 |
2025-07-15 |
Corxel Pharmaceuticals Hong Kong Limited |
Metalloenzyme inhibitor compounds
|
|
US12441703B2
(en)
|
2019-01-10 |
2025-10-14 |
Vertex Pharmaceuticals Incorporated |
Carboxamides as modulators of sodium channels
|
|
WO2020146612A1
(en)
|
2019-01-10 |
2020-07-16 |
Vertex Pharmaceuticals Incorporated |
Esters and carbamates as modulators of sodium channels
|
|
US12351577B2
(en)
|
2019-03-15 |
2025-07-08 |
Forma Therapeutics, Inc. |
Inhibiting cyclic AMP-responsive element-binding protein (CREB)
|
|
CN110982806B
(zh)
*
|
2019-08-30 |
2022-09-02 |
浙江工业大学 |
一种蛋白质芳基衍生物及其制备方法
|
|
DK4069691T3
(da)
|
2019-12-06 |
2024-10-28 |
Vertex Pharma |
Substituerede tetrahydrofuraner som modulatorer af natriumkanaler
|
|
CN111206260B
(zh)
*
|
2020-02-12 |
2022-03-22 |
齐鲁工业大学 |
一种吡啶并[1,2-a]苯并咪唑类化合物的电化学合成方法
|
|
US11795168B2
(en)
|
2020-09-23 |
2023-10-24 |
Forma Therapeutics, Inc. |
Inhibiting cyclic amp-responsive element-binding protein (CREB) binding protein (CBP)
|
|
US11801243B2
(en)
|
2020-09-23 |
2023-10-31 |
Forma Therapeutics, Inc. |
Bromodomain inhibitors for androgen receptor-driven cancers
|
|
MA64853B1
(fr)
|
2021-06-04 |
2025-11-28 |
Vertex Pharmaceuticals Incorporated |
N-(hydroxyalkyl (hétéro)aryl) tétrahydrofuran carboxamides utilisés en tant que modulateurs de canaux sodiques
|